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Summary
Background: Diabetes mellitus is an independent risk factor for cardiovascular events after
coronary artery bypass grafting (CABG), and hemoglobin A1c (HbA1c) is the most convenient
marker for monitoring glycemic control among diabetic patients. However, few studies have
reported the impact of baseline HbA1c levels on outcomes for diabetic patients after CABG. This
study therefore aimed to investigate whether preoperative HbA1c levels in diabetic patients
are predictive of long-term outcomes after off-pump CABG (OPCAB).
Methods and results: Of 893 patients undergoing primary isolated OPCAB at Juntendo University
Hospital from July 2002 to December 2007, subjects comprised 306 diabetic patients <80 years
old. We divided these patients into 3 groups according to the preoperative HbA1c levels. No sig-
niﬁcant differences in baseline characteristics, angiographic ﬁndings, or operative parameters
were apparent among the 3 groups. No operative or in-hospital mortality occurred. All-cause
mortality and cardiac mortality rates were 6.2% (19 cases) and 1.3% (4 cases), respectively.
Kaplan—Meier’s survival showed no signiﬁcant differences in all-cause or cardiac mortality (log-, resrank test, p = 0.26, p = 0.17
model also demonstrated that n
Conclusions: Preoperative HbA1
patients undergoing OPCAB. Car
management of CABG.
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c levels might not predict long-term outcomes for diabetic
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ntroduction
revious clinical studies have reported that clinical out-
omes after myocardial revascularization are signiﬁcantly
orse in diabetic patients than in non-diabetic patients
1—5]. Hemoglobin A1c (HbA1c) is a convenient and well-
nown biomarker in clinical practice. Indeed, observational
tudies have revealed that HbA1c level correlates with
ncreased cardiovascular events in primary and secondary
opulations [6,7]. However, the prognostic value of HbA1c
evel in diabetic patients remains controversial, particularly
mong patients with advanced coronary atherosclerotic dis-
ase [8—10]. This study aimed to investigate the impact of
reoperative HbA1c level on diabetic patients after coronary
rtery bypass grafting (CABG), particularly off-pump CABG
OPCAB).
ethods
tudy patients
f 893 patients undergoing primary isolated OPCAB at Jun-
endo University Hospital from July 2002 to December 2007,
ubjects comprised 311 diabetic patients at the time of
dmission. Diabetes mellitus was deﬁned as continuous
lasma glucose level ≥200mg/dl, fasting plasma glucose
evel ≥126mg/dl, 2-h plasma glucose levels in the 75 g oral
lucose tolerance test ≥200mg/dl, HbA1c level ≥6.5%, or
reatment with oral hypoglycemic drugs or insulin injec-
ion. Five cases were excluded because preoperative HbA1c
evels could not be obtained. Demographic data [includ-
ng age, gender and body mass index (BMI)], coronary
isk factors (hypertension, fasting total cholesterol, low-
ensity lipoprotein, high-density lipoprotein cholesterol,
riglycerides, fasting plasma glucose, smoking history, and
amily history of coronary artery disease), other comor-
idities (hemodialysis, cerebral infarction, and history of
alignancy), medication use, and operative parameters
ere prospectively recorded. Patients were divided into 3
roups according to the preoperative HbA1c levels: stan-
ard, HbA1c <6.5%; moderate, HbA1c ≥6.5% but <7.5%; or
igh, HbA1c ≥7.5%. This study was approved by the Inter-
al Review Board in our hospital and all procedures were
erformed according to the Helsinki Declaration.
urgical technique
PCAB was determined as the primary strategy for isolated
oronary artery disease except educational cases, cases with
nstable hemodynamics, and cases requiring multiple on-lay
nastomoses for diffuse calciﬁed lesions. The grafting strat-
gy was determined by several surgeons in our department
ccording to the patient background, perioperative condi-
ions and angiographic ﬁndings. OPCAB was performed under
ormothermia with warm intravenous ﬂuids administration.
ll cases underwent OPCAB without conversion to on-pump
ABG.
Median sternotomy was used to expose the heart. The
ericardium was opened with an inverted T-shaped incision
fter harvesting the internal mammary arteries. Arterial
i
i
w
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rafts were harvested as skeletonized conduits using an
ltrasonic scalpel (Harmonic Scalpel; Ethicon Endosurgery,
incinnati, OH, USA). After placing deep pericardial sutures
o expose target coronary vessels, the heart was stabi-
ized with a suction-irrigation tissue stabilization system
Octopus 3; Medtronic, Minneapolis, MN, USA). In cases
nvolving long anastomosis or ineffective proximal snaring,
ntracoronary shunt was used. Anastomosis of the saphe-
ous vein to the ascending aorta was performed with side
lamping. No proximal anastomotic assist devices were uti-
ized.
utcomes
he primary endpoints were all-cause mortality and car-
iac mortality. Cardiac mortality was deﬁned as death from
yocardial infarction (MI), arrhythmia, congestive heart
ailure, or sudden death. The secondary endpoint was to
ompare perioperative morbidity. Survival data were col-
ected by serial contact with patients or their families by
elephone interview. Details of mortality andmorbidity were
btained from the medical records of our hospitals or by
irect contact with follow-up physicians. Conﬁrmation of
urvival was performed between January 1 and February 27,
009.
tatistical analysis
tatistical analyses were performed using JMP version 8 soft-
are (SAS Institute Inc., Cary, NC, USA). In the comparison
f patient characteristics and operative outcomes, categor-
cal data are expressed as frequencies and percentages,
nd continuous variables are expressed as mean± standard
eviation. These data were compared using the 2-test
n case of categorical variables and continuous variables
ere compared using analysis of variance among 3 groups.
urvival curves were constructed for each group using
aplan—Meier’s methods and compared by log-rank testing.
-Values less than 0.05 were considered statistically signiﬁ-
ant. The efﬁcacy of preoperative HbA1c level after OPCAB
or predicting all-cause mortality was determined using mul-
ivariate Cox’s proportional-hazards regression analysis. The
odel was adjusted for the risk factors that were signiﬁcant
t a 0.20 level in the univariate analysis. Then, the interac-
ion between each risk factor and preoperative HbA1c was
ested at a 0.05 level. BMI was dropped from the model due
o non-signiﬁcant interaction.
esults
ll 306 patients were followed during the entire study
eriod. HbA1c level was deﬁned as standard in 115
atients (mean, 5.8± 0.4%), moderate in 96 patients (mean,
.9± 0.3%), and high in 95 patients (mean, 8.5± 0.9%).
aseline characteristics and angiographic ﬁndings were sim-
lar among the 3 groups (Table 1). Signiﬁcant differences
n preoperative triglyceride and fasting blood sugar levels
ere identiﬁed. One patient in the moderate HbA1c group
howed triglycerides >1300mg/dl. A total of 89 patients had
een on insulin therapy (standard, n = 21, 18.3%; moderate,
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Table 1 Baseline characteristics and demographic data based on differences in preoperative hemoglobin (Hb) A1c level
(standard level, HbA1c <6.5%; moderate level, HbA1c ≥6.5% but <7.5%; high level, HbA1c ≥7.5%).
Standard (n = 115) Moderate (n = 96) High (n = 95) p
Age (years) 58.5± 8.8 60.2± 8.5 60.9± 9.7 0.13
Male (%) 92 (79.3) 76 (79.2) 74 (77.9) 0.96
Body mass index (kg/m2) 23.9± 0.3 24.2± 0.3 23.9± 0.3 0.53
Hypertension (%) 88 (75.9) 68 (70.8) 64 (67.4) 0.38
Hyperlipidemia (%) 63 (54.3) 60 (62.5) 76 (67.4) 0.14
LDL-cholesterol (mg/dl) 108± 33 112± 36 116± 35 0.29
HDL-cholesterol (mg/dl) 44.6± 12 42.2± 12 44.9± 12 0.25
Triglyceride (mg/dl) 122± 61 162± 144 155± 98 0.013
Fasting blood sugar (mg/dl) 127.3± 36 153.5± 50 185.5± 59 <0.0001
Hemoglobin A1c (%) 5.8± 0.4 6.9± 0.3 8.5± 0.9 <0.0001
Smoking (%) 61 (52.6) 61 (63.5) 50 (53.2) 0.22
COPD (%) 3 (2.6) 3 (3.1) 1 (1.1) 0.60
Family history (%) 20 (17.4) 15 (15.6) 16 (16.8) 0.94
Cerebral infarction (%) 12 (10.6) 15 (15.6) 7 (7.5) 0.20
History of malignancy (%) 6 (5.3) 3 (3.1) 7 (7.4) 0.42
LVEF (%) 54.4± 14 56.4± 16 53.4± 15 0.47
Hemodialysis (%) 10 (8.6) 7 (7.3) 4 (4.2) 0.44
Serum creatininea (mg/dl) 1.1± 0.6 1.0± 0.4 0.9± 0.5 0.31
Number of vessels 2.6± 0.1 2.6± 0.1 2.6± 0.1 0.99
LMT ≥75% stenosis (%) 27 (23.5) 20 (21.1) 29 (31.2) 0.26
LDL, low-density lipoprotein; HDL, high-density lipoprotein; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection
fraction; LMT, left main trunk.
a Serum creatinine was determined after excluding patients who required hemodialysis due to chronic renal failure.
Table 2 Treatments for diabetes.
Standard (n = 115) Moderate (n = 96) High (n = 95) p
Insulin 21 (18.3) 26 (27.1) 42 (44.2) 0.0002
OHA 50 (43.5) 53 (55.2) 39 (41.1) 0.11
Diet only 43 (35.7) 16 (16.7) 13 (13.7) <.0001
(0)
rd le
4
m
wNo therapy 1 (0.9) 0
OHA, oral hypoglycemic agent. Hemoglobin (Hb) A1c level: standa
level, HbA1c ≥7.5%.
n = 26, 27.1%; high, n = 42, 44.2%; p = 0.0002), 143 patients
were on oral hypoglycemic agents (standard, n = 50, 43.5%;
moderate, n = 53, 55.2%; high, n = 39, 41.1%; p = 0.11), and
72 patients had received diet therapy alone (standard,
n = 43, 35.7%; moderate, n = 16, 16.7%; high, n = 13, 13.7%;
p < 0.0001) (Table 2). The number of distal anastomoses was
similar among the 3 groups (standard, 4.0± 0.1; moderate,
e
t
3
t
Table 3 Operative data.
Standard (n = 115)
Emergency (%) 8 (7.0)
Distal anastomoses 4.0± 0.1
ITA used (%) 115 (100)
Bilateral ITA used (%) 69 (60.0)
Operation time (min) 322± 74
Blood transfusion (%) 28 (27.5)
ITA, internal thoracic artery. Hemoglobin (Hb) A1c level: standard lev
level, HbA1c ≥7.5%.1 (0.9) 0.47
vel, HbA1c <6.5%; moderate level, HbA1c ≥6.5% but <7.5%; high
.0± 0.1; high, 4.0± 0.1; p = 0.80). Only 2 patients in the
oderate HbA1c group did not undergo arterial grafting
ith internal mammary artery (normal, n = 115, 100%; mod-
rate, n = 94, 97.9%; high, n = 95, 100%; p = 0.18). Operation
ime (standard, 322± 74min; moderate, 336± 83min; high,
34± 84min; p = 0.40) also did not differ signiﬁcantly among
he 3 groups (Table 3).
Moderate (n = 96) High (n = 95) p
10 (10.4) 11 (11.6) 0.48
4.0± 0.1 4.0± 0.1 0.80
94 (97.9) 95 (100) 0.18
49 (51.5) 57 (60.0) 0.34
336± 83 334± 84 0.40
19 (21.6) 19 (21.1) 0.51
el, HbA1c <6.5%; moderate level, HbA1c ≥6.5% but <7.5%; high
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Table 4 Perioperative complications.
Standard (n 115) Moderate (n = 96) High (n = 95) p
Re-exposure (%) 2 (1.7) 1 (1.0) 0 (0) 0.44
Low output syndrome (%) 0 (0) 0 (0) 1 (1.1) 0.33
Myocardial infarction (%) 0 (0) 0 (0) 0 (0) 0
Mediastinitis (%) 0 (0) 0 (0) 2 (2.1) 0.11
Pneumonia (%) 0 (0) 0 (0) 0 (0) 0
Renal failure (%) 2 (1.7) 1 (1.0) 2 (2.1) 0.84
Arrhythmia (%) 12 (10.4) 9 (9.4) 16 (16.8) 0.23
Stroke (%) 0 (0) 0 (0) 2 (2.1) 0.11
0 (0) 0 (0) 0
A1c <6.5%; moderate level, HbA1c ≥6.5% but <7.5%; high level, HbA1c
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Figure 1 Kaplan—Meier’s curves for all-cause mortality
according to the preoperative hemoglobin (Hb) A1c levels of
diabetic patients undergoing off-pump coronary artery bypass
grafting. Standard level (HbA1c <6.5%) vs. moderate level
(HbA1c ≥6.5% but <7.5%) vs. high level (HbA1c ≥7.5%).
Table 5 Multivariate analyses for all-cause mortality with
Cox’s proportional hazards model.
HR 95%CI p
Age 1.09 1.02—1.17 0.006
HbA1c 0.80 0.49—1.23 0.26
Triglyceride 1.00 0.99—1.00 0.47
Smoking 1.56 (0.54—5.05) 0.42
Gender (male) 2.08 (0.46—14.7) 0.36
Emergency 2.53 (0.70—7.52) 0.14
Hemodialysis 2.29 (0.50—7.63) 0.25
OHA 1.01 (0.30—3.71) 0.99GI complications (%) 0 (0)
GI, gastrointestinal. Hemoglobin (Hb) A1c level: standard level, Hb
≥7.5%.
erioperative outcomes
o signiﬁcant difference in frequency of perioperative com-
lications was seen among the 3 groups, although frequency
ended to be higher in the high HbA1c group. Complications
ncluded stroke in 2 cases (2.1%), mediastinitis in 2 cases
2.1%), and low output syndrome in 1 case (1.1%). Arrhyth-
ia (standard, n = 12, 10.4%; moderate, n = 9, 9.4%; high,
= 16, 16.8%; p = 0.23) was paroxysmal atrial ﬁbrillation in
ll except 1 case of ventricular tachycardia in standard
bA1c group. MI, pneumonia, and gastrointestinal compli-
ations did not occur among the 3 groups perioperatively
Table 4). In addition, no patients died during 30 days post-
peratively.
ong-term outcomes
ean duration of follow-up was 3.6± 1.7 years. During
ollow-up, 19 patients died (6.2%), including 4 cardiac
eaths (1.3%). Mortality due to causes other than cardiac
eath included cerebrovascular disease in 4 cases (21.1%),
alignancy in 8 cases (42.1%), renal failure in 1 case (5.3%),
neumonia in 1 case (5.3%), and gastrointestinal bleeding in
case (5.3%). Cardiac death included acute MI in 2 cases
50.0%) and congestive heart failure in 2 cases (50.0%).
umulative survival curves for all-cause mortality are shown
n Fig. 1. Log-rank testing showed no signiﬁcant difference
mong the 3 groups (p = 0.26). Cumulative survival curves
or cardiac mortality are shown in Fig. 2. No signiﬁcant
ifference was apparent among the groups (p = 0.17). Risk
nalyses using Cox’s proportional-hazard modeling are indi-
ated in Table 5. Age was the only signiﬁcant risk factor for
ll-cause mortality.
iscussion
ur study showed that preoperative HbA1c level was not
ssociated with long-termmortality among diabetic patients
ndergoing OPCAB. A unique feature of this study was the
nclusion of only patients who underwent OPCAB, which is
erformed more popularly in Japan than in other countries
11]. We have reported diabetes mellitus as an independent
isk factor for cardiovascular events after CABG [12]. In our
revious reports, we showed no data from diabetic patients
Insulin 1.73 (0.49—6.37) 0.39
HR, hazard ratio; CI, conﬁdence interval; Hb, hemoglobin; OHA,
oral hypoglycemic agent. HbA1c level: standard level, HbA1c
<6.5%; moderate level, HbA1c ≥6.5% but <7.5%; high level,
HbA1c ≥7.5%.
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RFigure 2 Kaplan—Meier’s curves for cardiac mortality accord-
ing to the preoperative hemoglobin (Hb) A1c levels.
regarding the effect of baseline glucose control on long-term
outcomes. To the best of our knowledge, this is the ﬁrst
study to report the impact of preoperative HbA1c level on
mortality in diabetic patients undergoing OPCAB.
Diabetic management using HbA1c level was utilized for
control in our daily clinical practice. In addition, the EPIC-
Norfolk study demonstrated that HbA1c level correlated
with increased cardiovascular events in a local community
follow-up study [6]. That observational study included pri-
mary care patients. Consistent with that study, Elley et al.
reported increased HbA1c as an independent risk factor for
cardiovascular disease in a large prospective cohort of type 2
diabetes patients without cardiovascular disease [7]. These
studies indicating correlations between elevated HbA1c and
adverse outcomes were prospective cohort studies for nor-
mal populations or patients with type 2 diabetes without
cardiovascular disease. Our study differs from those studies
in that patients required coronary revascularization, sug-
gesting that these patients displayed advanced coronary
artery disease with higher levels of co-morbidity.
In terms of prognostic value after coronary revascular-
ization, Corpus et al. demonstrated an association between
HbA1c and major adverse cardiac events in non-diabetic
patients undergoing percutaneous coronary intervention
(PCI) [13]. They suggested HbA1c levels of 6—7% as a sig-
niﬁcant independent predictor of major adverse cardiac
events after PCI. O’Sullivan et al. also suggested that HbA1c
levels of 6—7% may have prognostic signiﬁcance in non-
diabetic patients undergoing vascular surgery [8]. Halkos
et al. showed the impact of elevated preoperative HbA1c
level after CABG among over 3000 patients [9,14]. Periop-
eratively, for each unit increase in HbA1c, risks of MI and
deep sternal wound infection increased signiﬁcantly. As for
long-term survival, patients with HbA1c ≥7% showed lower
unadjusted 5-year survival compared to patients with HbA1c
<7%. However, the subjects of the large study included both
diabetic and non-diabetic patients. Indeed, no difference
in 5-year mortality was observed among diabetic patientspatients after OPCAB 185
ccording to the HbA1c levels ≥7% compared to <7% on the
nadjusted analysis. We considered that the impact of pre-
perative HbA1c level on long-term outcomes seemed to be
ifferent between non-diabetic and diabetic patients con-
iderably. In terms of non-diabetic patients, preoperative
bA1c reﬂected their potential glucose tolerance, whereas
he value of diabetes implied the efﬁcacy of their treat-
ents as well as impaired glucose tolerance.
Various explanations for the lack of predictive value
f preoperative HbA1c for long-term outcomes have been
entioned as follows. Firstly, it may be too late to pre-
ent macrovascular complications in diabetic patients with
dvanced coronary artery disease requiring CABG. Green-
eld et al. reported that diabetic patients with high levels
f comorbidity may receive diminished cardiovascular ben-
ﬁt from intensive glucose control [10]. Thus, we consider
hat early intervention for diabetes is necessary to acquire
ome beneﬁt.
Then, the morbidity andmortality rates were lower in our
tudy than in previous studies [9]. Severe wound infection
as been established as a crucial perioperative complica-
ion among patients with poor glycemic control [15,16]. In
he present study, two cases of mediastinitis occurred only
n the group of high HbA1c, however our multidisciplinary
pproach might avoid fatal outcomes. Moreover, no 30-day
r in-hospital deaths were encountered in our study. We con-
idered that this might be one of the reasons why the high
bA1c group showed the better long-term survival unex-
ectedly. Finally, the patients with high preoperative HbA1c
ight be treated intensively and tightly after operation than
hose with well-controlled HbA1c.
This study shows several limitations. This was not a ran-
omized control study. The subjects in this study comprised
homogeneous population and sample size was relatively
mall in spite of the lower mortality and morbidity rates. In
ddition, because we only obtained preoperative laboratory
ata, postoperative changes in HbA1c levels were not able to
e investigated. However, this would be signiﬁcant in terms
f data from patients undergoing only isolated OPCAB.
These results do not contradict the importance of
ntensive glucose control therapy after CABG. However,
reoperative intensive glycemic control therapy may not
e useful for diabetic patients with abnormally elevated
bA1c. Early intervention and rehabilitation may help
o improve survival after operations. In conclusion, ele-
ated preoperative HbA1c levels were not associated with
ong-term mortality in diabetic patients with advanced
therosclerosis who underwent OPCAB. Preoperative only
ingle measurement of HbA1c might not reﬂect the severity
f coronary atherosclerosis in diabetic patients. Therefore,
e believe that more careful evaluation for diabetes is
eeded in preoperative management of CABG.
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